An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Elizabeth Healthcare

Edgewood, Kentucky, 41017, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient seen within the St. Elizabeth system
>=18 years of age
New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later

Exclusion criteria

Patients with metastatic lung disease of other primary
Other malignancies at investigator's discretion
Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC
Patient currently undergoing treatment for new diagnosis of lung cancer

Treatment and study plan

Primary outcomes

Time from presentation to treatment

Time frame: from initial patient presentation with symptoms or incidental finding to first day of treatment, up to 3 years

Time from initial patient presentation with symptoms or incidental finding to first day of treatment, measured in days.

Secondary outcomes

Additional time between imaging and physician referrals

Time frame: From identification of concerning nodule to specialist appointment, up to 3 years

Sponsors and collaborators

Lead sponsor

St Elizabeth Healthcare

Other

Registry information

Acronym: TRACE

Important dates

Study start: 2018
Primary completion: 2021
Study completion: 2023
First posted: May 24, 2018
Registry last updated: Jul 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed